Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wilson PW et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97: 1837–1847

    Article  CAS  Google Scholar 

  2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486–2497

  3. Michos ED et al. (2005) Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 150: 1276–1281

    Article  Google Scholar 

  4. Ridker PM et al. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352: 1293–1304

    Article  CAS  Google Scholar 

  5. American Heart Association (2007) Heart Disease and Stroke Statistics–2007 Update [http://www.americanheart.org/downloadable/heart/11721754590102007%20Stat%20charts%20Circ%20Final%20v2.ppt#2] (accessed 16 April 2007)

  6. Mosca L et al. (2007) Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115: 1481–1501

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author has participated in trial steering committees for and received research grants and contracts from Merck, National Heart, Lung, and Blood Institute, and Pfizer. She has acted as a Consultant for Abbott, AstraZeneca, Bristol-Myers Squibb, CV Therapeutics, GlaxoSmithKline, Merck, NitroMed, Sanofi-Aventis, and Schering-Plough and has participated in the Speakers Bureau (CME only) for Bristol-Myers Squibb, CV Therapeutics, Eli Lilly, Merck, NitoMed, Novartis, and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wenger, N. The Reynolds Risk Score: improved accuracy for cardiovascular risk prediction in women?. Nat Rev Cardiol 4, 366–367 (2007). https://doi.org/10.1038/ncpcardio0913

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0913

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing